Andrew is an associate at Wilkinson Walsh + Eskovitz. He has significant experience in product liability, mass tort, securities, and other complex civil and corporate litigation matters. His representative matters include serving as a member of three trial teams that successfully defended Pfizer in litigation regarding the hormone therapy medication Prempro and against allegations that Pfizer failed to warn of the risk of developing breast cancer. Andrew was also a member of the defense team that successfully obtained dismissals on behalf of Citigroup in multiple derivative and securities fraud actions arising out of the 2008 financial crisis.
Before joining the firm, Andrew practiced as an associate in the Washington, D.C. office of Paul, Weiss, Rifkind, Wharton & Garrison LLP and the Baltimore office of Goodell, DeVries, Leech & Dann LLP. While in law school, Andrew served as an Articles Editor for the George Washington Law Review.